madman
Super Moderator
Androgen therapy in women requires regulatory approval and access to regulated preparations. Despite clear benefits in treating menopause symptoms, concerns about effectiveness and safety persist. Shared decision-making is necessary for prescribing hormone therapy at all life stages, including androgen therapy. Women with HSDD should have access to approved female transdermal testosterone therapy following appropriate assessment. There is a need for long-term research and the availability of approved female androgen formulations.
